The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy.
Ontology highlight
ABSTRACT: Mutations in cardiac troponin T (TnT) are a cause of familial hypertrophic cardiomyopathy (FHC). Transgenic mice expressing a missense mutation (R92Q) or a splice site donor mutation (Trunc) in the cardiac TnT gene have mutation-specific phenotypes but mice of both models have smaller hearts compared to wild type and exhibit hemodynamic dysfunction. Because growth-related signaling pathways in the hearts of mice expressing TnT mutations are not known, we evaluated the impact of increased Akt or glycogen synthase kinase-3beta (GSK-3beta) activity in both mutant TnT mice; molecules that increase heart size via physiologic pathways and block pathologic growth, respectively. Expression of activated Akt dramatically augments heart size in both R92Q and Trunc mice; however, this increase in hear
SUBMITTER: Luckey SW
PROVIDER: S-EPMC2701230 | biostudies-literature | 2009 May
REPOSITORIES: biostudies-literature
ACCESS DATA